Tyra Biosciences amends bylaws to adopt universal proxy rules and enhance stockholder proposal disclosure

Tyra Biosciences, Inc.

Board approved amended bylaws effective Oct 26, 2023.
Amendments require compliance with SEC Rule 14a-19 for proxy solicitations supporting non-Board nominees.
Enhanced procedural and disclosure requirements for stockholder director nominations and other business proposals.
Includes technical, modernizing and clarifying changes.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Tyra Biosciences, Inc.: Amended and restated bylaws to address universal proxy rules and enhance stockholder nomination procedures (effective 2023-10-26).

Change: bylaw amendment
Effective: 2023-10-26

Exact text from the filing

On October 26, 2023, the Board of Directors (the Board) of Tyra Biosciences, Inc. (the Company) approved and adopted amended and restated bylaws (the Amended and Restated Bylaws), which became effective the same day.

View on SEC.gov

59 governance changes filed in the last 30 days. Browse all governance changes →

Tyra Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-264152

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.